Academic Journal

A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor

التفاصيل البيبلوغرافية
العنوان: A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
المؤلفون: Roy, Tina, Barrows, Elizabeth, Mainor, Candace, Collins, Julie, Lynce, Filipa, Isaacs, Claudine, Pohlmann, Paula R.
المصدر: Contemporary Clinical Trials Communications ; volume 33, page 101110 ; ISSN 2451-8654
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.conctc.2023.101110
الاتاحة: http://dx.doi.org/10.1016/j.conctc.2023.101110
https://api.elsevier.com/content/article/PII:S245186542300056X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S245186542300056X?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.9BC142D9
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.conctc.2023.101110